Skip to Content

Bunge Limited

Merger

  • Date:
  • 6/14/2023
  • Company Name:
  • Bunge Limited
  • Stock Symbol:
  • BG
  • Company Name - Buyer:
  • Viterra Limited
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 6/13/2023

Case Finder

Locate any case using the tools below.

NEW YORK, June 14, 2023 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Bunge Limited (NYSE: BG) (“Bunge”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Viterra Limited (“Viterra”).

On June 13, 2023, Bunge announced that it had entered into an agreement to be acquired by Viterra in a $6.2 billion stock and cash deal. Pursuant to the merger agreement, Viterra shareholders would receive approximately 65.6 million shares of Bunge stock and approximately $2.0 billion in cash. Bunge will assume $9.8 billion of Viterra debt and plans to repurchase $2.0 billion of Bunge’s stock (“Repurchase Plan”). Viterra shareholders would own 30% of the combined company on a fully diluted basis upon the close of the transaction, and approximately 33% after completion of the Repurchase Plan. The deal is expected to close in mid-2024.

Bragar Eagel & Squire is concerned that Bunge's board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Bunge's stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Bunge Limited. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: